The Nuclear Medicine Department at Mahatma Gandhi University of Medical Sciences & Technology is a state-of-the-art facility dedicated to advanced diagnostic imaging, molecular research, and targeted radionuclide therapy.
The department combines cutting-edge imaging technologies with a multidisciplinary team of qualified specialists to deliver precise, patient-centred care.
Equipped with two PET/CT scanners and a high-performance SPECT system, the department provides comprehensive functional imaging services for oncology, cardiology, neurology, and other specialties. The PET-CT units support high-resolution, quantitative imaging, enabling accurate disease staging, treatment planning, and monitoring of therapy.
A wide range of radiopharmaceuticals is available, including F-18 Fluorodeoxyglucose (FDG) for metabolic imaging and Gallium-68-based tracers for receptor imaging, viz., neuroendocrine tumors, prostate cancer, insulinoma, parathyroid, etc. The facility also conducts radionuclide therapy, offering targeted treatments such as I-131 for thyroid disorders, and other personalized radiotherapeutic procedures under strict radiation safety supervision, such as Lu-177 therapies for neuroendocrine tumors and prostate cancer, and metastatic bone pain palliation.